Nordic Capital offers to acquire Advanz Pharma for $846m
Nordic Capital has made an offer to acquire Advanz Pharma, a UK-based specialty pharma company, for about $846 million in cash. Advanz Pharma is said to focus strategically on complex medicines in Europe. The company’s expertise is in the anti-infectives and endocrinology therapy areas. As per the terms of the proposed deal, Advanz Pharma’s shareholders […]